Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

PENICILLIN AND THE STREPTOCOCCUS

PENICILLIN AND THE STREPTOCOCCUS This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables. Abstract To the Editor: Recognizing the fact that medical progress is in part measured by new therapies I am nevertheless disturbed by the article "Beta Hemolytic Streptococcal Illness" (Amer J Dis Child112: 21-27, 1966). Evaluating the effectiveness of ampicillin (Penbritin, Polycillin, Omnipen) and lincomycin hydrochloride monohydrate (Lincocin) in the treatment of streptococcal disease in children implies, by matter of association with penicillin G, their acceptibility as modes of therapy in streptococcal disease. The point should be made that despite the fact these drugs work, they are certainly not acceptable substitutes for penicillin in cases of pure streptococcal illness. It should be stressed that they have very definite properties and advantages which should suggest their use at specified times only. The problem of emergence of drug resistant organisms is a most serious one. Fortunately, β-hemolytic streptococci have remained sensitive to penicillin despite its continued widespread use. Let's not exhaust our armamentarium. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png American Journal of Diseases of Children American Medical Association

PENICILLIN AND THE STREPTOCOCCUS

Loading next page...
 
/lp/american-medical-association/penicillin-and-the-streptococcus-iCU6KbYCBt

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Medical Association
Copyright
Copyright © 1966 American Medical Association. All Rights Reserved.
ISSN
0002-922X
DOI
10.1001/archpedi.1966.02090150152025
Publisher site
See Article on Publisher Site

Abstract

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables. Abstract To the Editor: Recognizing the fact that medical progress is in part measured by new therapies I am nevertheless disturbed by the article "Beta Hemolytic Streptococcal Illness" (Amer J Dis Child112: 21-27, 1966). Evaluating the effectiveness of ampicillin (Penbritin, Polycillin, Omnipen) and lincomycin hydrochloride monohydrate (Lincocin) in the treatment of streptococcal disease in children implies, by matter of association with penicillin G, their acceptibility as modes of therapy in streptococcal disease. The point should be made that despite the fact these drugs work, they are certainly not acceptable substitutes for penicillin in cases of pure streptococcal illness. It should be stressed that they have very definite properties and advantages which should suggest their use at specified times only. The problem of emergence of drug resistant organisms is a most serious one. Fortunately, β-hemolytic streptococci have remained sensitive to penicillin despite its continued widespread use. Let's not exhaust our armamentarium.

Journal

American Journal of Diseases of ChildrenAmerican Medical Association

Published: Dec 1, 1966

There are no references for this article.